A named list, and what it says
We parsed the list and matched it name by name against the fifty state names and the District of Columbia. Thirty-eight states are present, the District of Columbia is present, and twelve states are absent. The site adds that it is working to expand.
The framing matters as much as the list. The page says these are the states its partner pharmacy is licensed to provide services in, not simply the states it serves. That is a statement about the supply chain rather than about marketing reach, and it is the sort of thing a reader can take to a pharmacy board register.
One price, and it belongs to no drug
The homepage carries a single starting-at figure beside the words naming both drugs. It is not scoped to semaglutide or to tirzepatide, no dose ladder appears anywhere, and no plan term is stated beside it. We have stored it against the general GLP-1 category rather than attributing it to a molecule it does not name.
Its billing terms are stated more clearly than its prices. The FAQ says a patient is charged for a first month or a three-month programme at signup, is refunded in full if a doctor does not approve them, and has to repurchase to continue rather than being auto-renewed.
The partner pharmacy is not named
The same FAQ that publishes the state list describes the pharmacy only as a partner licensed compounding pharmacy. It explains what a compounding pharmacy is, in general terms, and never says which one this is.
No operating company is named either. We read the about page and ran a widened corporate-suffix pattern across every cached page on the host; nothing came back.
Medica Weight Loss's published pricing
| Medication | Price | Verified |
|---|---|---|
| Glp-1 (compounded) | $197/mopublished as "Plans starting at $197" beside the words "Semaglutide & Tirzepatide medications"; the figure is not scoped to either drug and no dose ladder appears | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See Medica Weight Loss's current price →Good fit if
- Readers outside the largest states who want to check a named list before starting an intake.
- Buyers who want no auto-renewal and a refund if a doctor declines them.
- People who prefer a claim about pharmacy licensing to a claim about service area.
Look elsewhere if
- Readers who need a price for a specific drug; the one published figure names neither.
- Anyone in one of the twelve states the list does not contain.
- Buyers who want the compounding pharmacy or the operating company named.
- Readers for whom an FDA warning letter is disqualifying.
How this review was verified
- Re-read the priced homepage and the about page on 7 September 2026, comparing requested to effective URLs and running a nonsense path against the host in the same run, which returned a 404.
- Parsed the state list programmatically and matched it against the fifty state names and the District of Columbia, rather than reading a heading — which is how a thirty-eight-state list stops being reported as a national one.
- Stored the single published figure against the general GLP-1 category, because the page does not scope it to a molecule.
- Ran a widened corporate-suffix pattern across every cached body on the host, proved first against a page known to name a company; it returned nothing here.
- Screened the brand against FDA's live warning-letter datatable with a positive and a negative control in the same invocation; thirty-six word matches came back, each was read, and one is this seller. The letter was re-fetched and its title checked against the reference number and date.